Filing Details
- Accession Number:
- 0001562180-15-000489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-17 15:55:52
- Reporting Period:
- 2015-06-15
- Filing Date:
- 2015-06-17
- Accepted Time:
- 2015-06-17 15:55:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1042021 | M Jeffrey Jonas | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-15 | 83,374 | $0.45 | 89,374 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-15 | 1,554 | $83.89 | 87,820 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-15 | 2,420 | $81.51 | 85,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-15 | 5,707 | $79.97 | 79,693 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-15 | 62,364 | $78.88 | 17,329 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-15 | 11,329 | $78.22 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-16 | 115,226 | $0.45 | 121,226 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-16 | 6,804 | $78.13 | 114,422 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-16 | 14,146 | $76.85 | 100,276 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-16 | 64,973 | $76.09 | 35,303 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-16 | 29,303 | $75.51 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-15 | 32,745 | $0.45 | 38,745 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-16 | 45,255 | $0.45 | 84,000 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-15 | 128,629 | $0.00 | 128,629 | $0.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-16 | 147,971 | $0.00 | 147,971 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-08-12 | No | 4 | M | Direct | |
| 0 | 2023-08-12 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $75.50 USD to $75.55 USD. The price reported above reflects the weighted average sale price.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option shall vest in full on August 12, 2017, subject to continued service through such date.
- This transaction was executed in multiple trades at prices ranging from $83.79 USD to $84.01 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $80.64 USD to $81.63 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $79.625 USD to $80.61 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $78.58 USD to $79.58 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $77.86 USD to $78.44 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $77.60 USD to $78.595 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $76.56 USD to $77.56 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $75.555 USD to $76.555 USD. The price reported above reflects the weighted average sale price.
Billionaire Hedge Funds
